The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 von Salgado, R., Denkert, C., Demaria, S., Sirtaine, N., Klauschen, F., Pruneri, G., Wienert, S., Van den Eynden, G., Baehner, F.L., Penault-Llorca, F., Perez, E.A., Thompson, E.A., Symmans, W.F., Richardson, A.L., Brock, J., Criscitiello, C., Bailey, H., Ignatiadis, M., Floris, G., Sparano, J., Kos, Z., Nielsen, T., Rimm, D.L., Allison, K.H., Reis-Filho, J.S., Loibl, S., Sotiriou, C., Viale, G., Badve, S., Adams, S., Willard-Gallo, K., Loi, S.

Volltext

Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning von Klauschen, F., Müller, K.-R., Binder, A., Bockmayr, M., Hägele, M., Seegerer, P., Wienert, S., Pruneri, G., de Maria, S., Badve, S., Michiels, S., Nielsen, T.O., Adams, S., Savas, P., Symmans, F., Willis, S., Gruosso, T., Park, M., Haibe-Kains, B., Gallas, B., Thompson, A.M., Cree, I., Sotiriou, C., Solinas, C., Preusser, M., Hewitt, S.M., Rimm, D., Viale, G., Loi, S., Loibl, S., Salgado, R., Denkert, C.

Volltext

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer von Pruneri, G., Vingiani, A., Bagnardi, V., Rotmensz, N., De Rose, A., Palazzo, A., Colleoni, A.M., Goldhirsch, A., Viale, G.

Volltext

ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4) von Paluch-Shimon, S., Cardoso, F., Partridge, A.H., Abulkhair, O., Azim, H.A., Bianchi-Micheli, G., Cardoso, M.-J., Curigliano, G., Gelmon, K.A., Harbeck, N., Merschdorf, J., Poortmans, P., Pruneri, G., Senkus, E., Spanic, T., Stearns, V., Wengström, Y., Peccatori, F., Pagani, O.

Volltext

ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5) von Paluch-Shimon, S., Cardoso, F., Partridge, A.H., Abulkhair, O., Azim, H.A., Bianchi-Micheli, G., Cardoso, M.J., Curigliano, G., Gelmon, K.A., Gentilini, O., Harbeck, N., Kaufman, B., Kim, S.B., Liu, Q., Merschdorf, J., Poortmans, P., Pruneri, G., Senkus, E., Sirohi, B., Spanic, T., Sulosaari, V., Peccatori, F., Pagani, O.

Volltext

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer von Tarantino, P., Viale, G., Press, M.F., Hu, X., Penault-Llorca, F., Bardia, A., Batistatou, A., Burstein, H.J., Carey, L.A., Cortes, J., Denkert, C., Diéras, V., Jacot, W., Koutras, A.K., Lebeau, A., Loibl, S., Modi, S., Mosele, M.F., Provenzano, E., Pruneri, G., Reis-Filho, J.S., Rojo, F., Salgado, R., Schmid, P., Schnitt, S.J., Tolaney, S.M., Trapani, D., Vincent-Salomon, A., Wolff, A.C., Pentheroudakis, G., André, F., Curigliano, G.

Volltext

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials von Peto, R, Davies, C, Godwin, J, Gray, R, Pan, H C, Clarke, M, Cutter, D, Darby, S, McGale, P, Taylor, C, Wang, Y C, Bergh, J, Di Leo, A, Albain, K, Swain, S, Piccart, M, Pritchard, K

Volltext

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast von Pruneri, G., Lazzeroni, M., Bagnardi, V., Tiburzio, G.B., Rotmensz, N., DeCensi, A., Guerrieri-Gonzaga, A., Vingiani, A., Curigliano, G., Zurrida, S., Bassi, F., Salgado, R., Van den Eynden, G., Loi, S., Denkert, C., Bonanni, B., Viale, G.

Volltext

Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues von Busico, A., Gasparini, P., Rausa, E., Cattaneo, L., Bozzi, F., Silvestri, M., Capone, I., Conca, E., Tamborini, E., Perrone, F., Vitellaro, M., Ricci, M.T., Casanova, M., Chiaravalli, S., Bergamaschi, L., Massimino, M., Milione, M., Sozzi, G., Pruneri, G., Ferrari, A., Signoroni, S.

Volltext

The effect of metformin on apoptosis in a breast cancer presurgical trial von Cazzaniga, M, DeCensi, A, Pruneri, G, Puntoni, M, Bottiglieri, L, Varricchio, C, Guerrieri-Gonzaga, A, Gentilini, O D, Pagani, G, Dell'Orto, P, Lazzeroni, M, Serrano, D, Viale, G, Bonanni, B

Volltext

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer von Cancello, G., Maisonneuve, P., Rotmensz, N., Viale, G., Mastropasqua, M.G., Pruneri, G., Veronesi, P., Torrisi, R., Montagna, E., Luini, A., Intra, M., Gentilini, O., Ghisini, R., Goldhirsch, A., Colleoni, M.

Volltext

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer von Criscitiello, C., Bayar, M.A., Curigliano, G., Symmans, F.W., Desmedt, C., Bonnefoi, H., Sinn, B., Pruneri, G., Vicier, C., Pierga, J.Y., Denkert, C., Loibl, S., Sotiriou, C., Michiels, S., André, F.

Volltext

79. Why we do not need genomic profiling von Pruneri, G

Volltext

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group von Ryan, G., Martinelli, G., Kuper-Hommel, M., Tsang, R., Pruneri, G., Yuen, K., Roos, D., Lennard, A., Devizzi, L., Crabb, S., Hossfeld, D., Pratt, G., Dell'Olio, M., Choo, S. P., Bociek, R. G., Radford, J., Lade, S., Gianni, A. M., Zucca, E., Cavalli, F., Seymour, J. F.

Volltext

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer tr... von Gourgou-Bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F., A'Hern, R., Bliss, J., Bogaerts, J., Bonnefoi, H., Brain, E., Cardoso, M.J., Chibaudel, B., Coleman, R., Cufer, T., Dal Lago, L., Dalenc, F., De Azambuja, E., Debled, M., Delaloge, S., Filleron, T., Gligorov, J., Gutowski, M., Jacot, W., Kirkove, C., MacGrogan, G., Michiels, S., Negreiros, I., Offersen, B.V., Penault Llorca, F., Pruneri, G., Roche, H., Russell, N.S., Schmitt, F., Servent, V., Thürlimann, B., Untch, M., van der Hage, J.A., van Tienhoven, G., Wildiers, H., Yarnold, J., Bonnetain, F., Mathoulin-Pélissier, S., Bellera, C., Dabakuyo-Yonli, T.S.

Volltext

Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis von Gerboth, S, Frittoli, E, Palamidessi, A, Baltanas, F C, Salek, M, Rappsilber, J, Giuliani, C, Troglio, F, Rolland, Y, Pruneri, G, Kreutmair, S, Pallavicini, I, Zobel, M, Cinquanta, M, Minucci, S, Gomez, C, Santos, E, Illert, A L, Scita, G

Volltext

Plasmablastic lymphoma: a review von Rafaniello Raviele, P, Pruneri, G, Maiorano, E

Volltext

Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Tr... von Rusakiewicz, S., Tyekucheva, S., Tissot-Renaud, S., Chaba, K., Imbimbo, M., Benedetti, F., Kammler, R., Hornfeld, J., Munzone, E., Gianni, L., Thurlimann, B., Láng, I., Pruneri, G., Gray, K.P., Regan, M.R., Loi, S., Colleoni, M., Viale, G., Kandalaft, L., Coukos, G., Curigliano, Giuseppe

Volltext

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse von Cancello, G., Maisonneuve, P., Rotmensz, N., Viale, G., Mastropasqua, M.G., Pruneri, G., Montagna, E., Iorfida, M., Mazza, M., Balduzzi, A., Veronesi, P., Luini, A., Intra, M., Goldhirsch, A., Colleoni, M.

Volltext

Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO von Pizzamiglio, S., Ciniselli, C. M., de Azambuja, E., Agbor-tarh, D., Moreno-Aspitia, A., Suter, T. M., Trama, A., De Santis, M. C., De Cecco, L., Iorio, M. V., Silvestri, M., Pruneri, G., Verderio, P., Di Cosimo, S.

Volltext